Clinical trials
Hyperparathyroidism clinical trials
Below are recruiting hyperparathyroidism clinical trials, each written for real people, not researchers. We’re tracking 31 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05997810Recruiting
Parathyroid tumor genetics study
This study looks at the genetic makeup of parathyroid tumors in people with hyperparathyroidism. It aims to understand why these tumors form and how they behave, which could help improve treatment decisions.
St Louis, MissouriAges 18–80 - NCT07444723RecruitingPhase 2/Phase 3
New imaging to find parathyroid tumors before surgery
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
Bethesda, MarylandAges 18–100 - NCT04922892Recruiting
Compare two parathyroid surgeries for severe kidney-related hormone imbalance
This trial compares two surgical approaches for severe secondary hyperparathyroidism caused by kidney disease: removing all parathyroid tissue alone versus removing it and moving some tissue back into the body. The study aims to see which approach works better and is safer for controlling the hormone problem.
NanjingAges 18–70 - NCT03633708RecruitingPhase 3
Etelcalcetide for children with dialysis-related overactive parathyroid hormone
This trial studies etelcalcetide in children who have chronic kidney disease and too much parathyroid hormone while on hemodialysis. It aims to safely lower the hormone levels and help manage related bone/mineral problems.
Los Angeles, CaliforniaAges birth–18 years - NCT03969329RecruitingPhase 3
Etelcalcetide for children on dialysis with high parathyroid hormone
This Phase 3 trial tests etelcalcetide to lower a hormone called parathyroid hormone (PTH) in children who have kidney disease and secondary hyperparathyroidism while on hemodialysis. It may help control bone/mineral problems, but the study also checks heart rhythm safety and medication stability.
GhentAges 2–17 - NCT05469087Recruiting
Study of primary hyperparathyroidism in adults
This study follows adults with primary hyperparathyroidism (a hormone-related condition that affects calcium levels). It aims to better understand the condition and who it affects, which may help improve care over time.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT06230380Recruiting
Autofluorescence camera in parathyroid surgery
This trial tests whether a special camera (autofluorescence) can help surgeons find abnormal parathyroid glands during surgery for primary hyperparathyroidism. It involves exploratory surgery, not a focused approach, and may help improve surgical success.
AarhusAges 18 years+ - NCT06562881Recruiting
Helping People Get Parathyroid Surgery When Needed
This study looks at whether a patient navigator (a person who helps guide you through the healthcare system) can help people who need surgery for primary hyperparathyroidism but may face barriers due to race, income, or insurance. It aims to make surgery more accessible and improve outcomes.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06859580RecruitingPhase 4
Bisphosphonate before parathyroid surgery for bone health
This study tests whether giving a bisphosphonate (a bone-strengthening drug) before parathyroid surgery helps protect bone health in people with primary hyperparathyroidism. It's for those who already have thin bones and are planning surgery.
Aarhus N, Central Region of DenmarkAges 50 years+ - NCT06976177RecruitingPhase 2
MT1013 for secondary hyperparathyroidism in dialysis patients
This study tests a new injectable medicine called MT1013 for people with secondary hyperparathyroidism who are on regular kidney dialysis. It aims to see if MT1013 can help control high parathyroid hormone levels safely.
Hangzhou, ZhejiangAges 18 years+ - NCT07122401RecruitingPhase 3
Study of MT1013 for dialysis patients with high parathyroid hormone
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07138820Recruiting
Comparing scans to find parathyroid gland disease
This study compares a newer type of scan (18F-choline PET/CT) to standard imaging to help doctors locate overactive parathyroid glands. The goal is to see if the newer scan works better for planning surgery in people with primary hyperparathyroidism.
LundAges 18 years+ - NCT07494045RecruitingPhase 2
Study of CTAP101 for kids with chronic kidney disease
This study tests a new extended-release capsule (CTAP101) for children aged 8 to under 18 with moderate to severe chronic kidney disease (CKD). The goal is to see how the drug works in the body, if it's safe, and if it can help control mineral and hormone levels that are often out of balance in CKD.
Kansas City, MissouriAges 1 month–17 years - NCT07744425Enrolling by invitation
Surgical imaging device study
This study tests a new camera that helps surgeons see tissues more clearly during surgery. It may help improve surgical precision and safety.
Palo Alto, CaliforniaAges 18–90 - NCT03039439Recruiting
Tissue study of parathyroid tumors to understand tumor biology
This study looks at blood and/or tissue samples from people with parathyroid problems to better understand different types of parathyroid tumors. It does not test a new medicine—instead, researchers analyze samples to learn what makes each tumor type different.
Houston, TexasAges Any age - NCT03935984RecruitingPhase 4
Calcitonin before scan to improve parathyroid detection
This study looks at whether taking calcitonin before a special parathyroid scan (SPECT-CT) makes the scan easier to read. It’s for people with primary hyperparathyroidism who want surgery, and may help doctors find the right gland more reliably.
Toledo, OhioAges 18 years+ - NCT04969926Recruiting
Study of parathyroid problems in children and adults
This is an observational study that follows people who have or may develop parathyroid-related conditions. The goal is to better understand how these problems change over time and what patterns show up, which can help improve future care.
Bethesda, MarylandAges 6 months–100 years - NCT05667090Recruiting
High-dose vitamin D3 to ease chronic pain in dialysis patients
This study tests whether taking a very high dose of vitamin D3 can reduce moderate to severe chronic pain in people on hemodialysis. It may help by improving vitamin D-related pathways that could affect pain, but you must also meet specific health and testing requirements.
TaipeiAges 20 years+ - NCT05880914Recruiting
Personalized treatment study for bone disease in kidney failure
This trial looks at a personalized approach to diagnosing and treating bone problems caused by long-term kidney disease. It may help by matching treatment plans to the type of bone turnover found in your tests or biopsy.
St Louis, MissouriAges 18 years+ - NCT05963841Recruiting
Testing AI to improve parathyroid scan imaging
This study uses past and future parathyroid scan data to train and test an AI tool. The goal is to improve how the scans are interpreted using nuclear medicine imaging from a specific scanning process.
BesançonAges 18 years+ - NCT06126016Recruiting
A study of Pacitol Inj. for dialysis patients with parathyroid issues
This study watches how well the drug Pacitol Inj. works and how safe it is in people on dialysis who have overactive parathyroid glands caused by kidney disease. It follows patients who are already prescribed this drug by their doctor.
Goyang-si, Gyeonggi-doAges 19 years+ - NCT06450431Recruiting
Parathyroid symptom assessment study
This study looks at how your parathyroid condition affects your symptoms and quality of life. You will fill out a simple questionnaire about your health.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT06523582Recruiting
Genetic study of neuroendocrine tumors in Mexican patients
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Mexico City, Mexico CityAges 18 years+ - NCT06797934Recruiting
Registry for people with parathyroid disease
This trial is creating a registry (a database) for people with parathyroid disease. It will collect information to help doctors better understand and treat these conditions.
Bologna, BolognaAges 18 years+
Hear when a new Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hyperparathyroidism?
- Yes. Clin2 currently lists 31 recruiting hyperparathyroidism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hyperparathyroidism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hyperparathyroidism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.